Systemic Lupus Erythematosus, New England Journal of Medicine, vol.358, issue.9, pp.929-939, 2008. ,
DOI : 10.1056/NEJMra071297
Genetic susceptibility to systemic lupus erythematosus in the genomic era, Nature Reviews Rheumatology, vol.18, issue.12, pp.683-692, 2010. ,
DOI : 10.1038/nrrheum.2010.176
B cells in autoimmunity, Proceedings of the National Academy of Sciences, vol.97, issue.16, pp.8750-8751, 2000. ,
DOI : 10.1073/pnas.97.16.8750
The role of B cells in lupus pathogenesis, The International Journal of Biochemistry & Cell Biology, vol.42, issue.4, pp.543-550, 2010. ,
DOI : 10.1016/j.biocel.2009.10.011
Role of anti-DNA antibodies in the pathogenesis of lupus nephritis, Autoimmunity Reviews, vol.5, issue.6, pp.414-418, 2006. ,
DOI : 10.1016/j.autrev.2005.10.010
plasma cells and disease activity in patients with systemic lupus erythematosus, Arthritis & Rheumatism, vol.65, issue.Suppl 14, pp.1332-1342, 2003. ,
DOI : 10.1002/art.10949
Are autoantibodies the targets of B-cell-directed therapy?, Nature Reviews Rheumatology, vol.9, issue.9, pp.551-556, 2011. ,
DOI : 10.1038/nrrheum.2011.108
Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients, Arthritis Research & Therapy, vol.12, issue.3, p.108, 2010. ,
DOI : 10.1186/ar3042
Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus, Arthritis Research & Therapy, vol.12, issue.6, p.204, 2010. ,
DOI : 10.1186/ar3179
How chemokines invite leukocytes to dance, Nature Immunology, vol.12, issue.9, pp.953-959, 2008. ,
DOI : 10.1038/ni.f.207
Inflammatory Cytokines in Systemic Lupus Erythematosus, Journal of Biomedicine and Biotechnology, vol.181, issue.5, p.432595, 2011. ,
DOI : 10.1007/s11033-010-0527-y
Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement, Lupus, vol.54, issue.8, pp.845-854, 2011. ,
DOI : 10.2741/2188
Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus, Expert Opinion on Therapeutic Targets, vol.8, issue.10, pp.1147-1153, 2009. ,
DOI : 10.1128/AAC.00013-07
Chemokines in lymphopoiesis and lymphoid organ development, Current Opinion in Immunology, vol.13, issue.2, pp.172-179, 2001. ,
DOI : 10.1016/S0952-7915(00)00201-6
Differences in CXCR4-mediated signaling in B cells, Immunobiology, vol.211, issue.5, pp.377-389, 2006. ,
DOI : 10.1016/j.imbio.2005.12.003
Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus, Arthritis & Rheumatism, vol.48, issue.Suppl 1, pp.3436-3446, 2010. ,
DOI : 10.1002/art.27685
Role of the Chemokine Stromal Cell-Derived Factor 1 in Autoantibody Production and Nephritis in Murine Lupus, The Journal of Immunology, vol.170, issue.6, pp.3392-3400, 2003. ,
DOI : 10.4049/jimmunol.170.6.3392
URL : https://hal.archives-ouvertes.fr/pasteur-00166866
Molecular Characterization of Circulating Plasma Cells in Patients with Active Systemic Lupus Erythematosus, PLoS ONE, vol.7, issue.9, p.44362, 2012. ,
DOI : 10.1371/journal.pone.0044362.s002
CXCR7, CXCR4 and CXCL12: An eccentric trio?, Journal of Neuroimmunology, vol.198, issue.1-2, pp.9-13, 2008. ,
DOI : 10.1016/j.jneuroim.2008.04.020
Atypical chemokine receptors, Experimental Cell Research, vol.317, issue.5, pp.556-568, 2011. ,
DOI : 10.1016/j.yexcr.2011.01.012
CXCR7 Functions as a Scavenger for CXCL12 and CXCL11, PLoS ONE, vol.5, issue.2, pp.7-9175, 2010. ,
DOI : 10.1371/journal.pone.0009175.s002
The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12, Blood, vol.119, issue.2, pp.465-468, 2011. ,
DOI : 10.1182/blood-2011-03-343608
Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands, Oncogene, vol.110, issue.32, pp.4599-4610, 2010. ,
DOI : 10.1038/onc.2010.212
Rapid Uptake and Degradation of CXCL12 Depend on CXCR7 Carboxyl-terminal Serine/Threonine Residues, Journal of Biological Chemistry, vol.287, issue.34, pp.28362-28377, 2012. ,
DOI : 10.1074/jbc.M111.335679
??-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7, Proceedings of the National Academy of Sciences, vol.107, issue.2, pp.628-632, 2010. ,
DOI : 10.1073/pnas.0912852107
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling, Blood, vol.113, issue.24, pp.6085-6093, 2009. ,
DOI : 10.1182/blood-2008-12-196618
URL : https://hal.archives-ouvertes.fr/pasteur-00415320
/ CXCR4 Heterodimer Constitutively Recruits {beta}-Arrestin to Enhance Cell Migration, J Biol Chem, vol.286, pp.732188-32197, 2011. ,
Ubiquitination of CXCR7 Controls Receptor Trafficking, PLoS ONE, vol.133, issue.3, p.34192, 2012. ,
DOI : 10.1371/journal.pone.0034192.s007
The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes, Journal of Biological Chemistry, vol.280, issue.42, pp.35760-35766, 2005. ,
DOI : 10.1074/jbc.M508234200
Expression and Regulation of the Orphan Receptor RDC1 and Its Putative Ligand in Human Dendritic and B Cells, The Journal of Immunology, vol.176, issue.4, pp.2197-2207, 2006. ,
DOI : 10.4049/jimmunol.176.4.2197
CXCR7 Protein Is Not Expressed on Human or Mouse Leukocytes, The Journal of Immunology, vol.185, issue.9, pp.75130-5139, 2010. ,
DOI : 10.4049/jimmunol.1001660
Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95, Arthritis & Rheumatism, vol.14, issue.6, pp.1762-1773, 2008. ,
DOI : 10.1002/art.23498
Complementary methods provide evidence for the expression of CXCR7 on human B cells, PROTEOMICS, vol.118, issue.12, pp.1938-1948, 2012. ,
DOI : 10.1002/pmic.201100581
Genetic admixture and diversity estimations in the Mexican Mestizo population from Mexico City using 15 STR polymorphic markers, Forensic Science International: Genetics, vol.2, issue.3, pp.37-39, 2008. ,
DOI : 10.1016/j.fsigen.2007.08.017
The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis & Rheumatism, vol.31, issue.11, pp.1271-1277, 1982. ,
DOI : 10.1002/art.1780251101
Derivation of the sledai. A disease activity index for lupus patients, Arthritis & Rheumatism, vol.19, issue.6, pp.630-640, 1992. ,
DOI : 10.1002/art.1780350606
The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients, Rheumatology, vol.50, issue.5, pp.982-988, 2011. ,
DOI : 10.1093/rheumatology/keq376
Selective Loss of Chemokine Receptor Expression on Leukocytes after Cell Isolation, PLoS ONE, vol.183, issue.3, p.31297, 2012. ,
DOI : 10.1371/journal.pone.0031297.t002
Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling, Journal of Clinical Investigation, vol.118, pp.1074-1084, 2008. ,
DOI : 10.1172/JCI33187
URL : https://hal.archives-ouvertes.fr/hal-00259431
Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis, BMC Molecular Biology, vol.8, issue.1, p.113, 2007. ,
DOI : 10.1186/1471-2199-8-113
Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus, Arthritis Research & Therapy, vol.7, issue.5, pp.1001-1013, 2005. ,
DOI : 10.1186/ar1776
Expression of chemokine receptors CXCR4, CXCR5 and CCR7 on B and T lymphocytes from patients with primary antibody deficiency, Clinical & Experimental Immunology, vol.112, issue.2, pp.254-262, 2009. ,
DOI : 10.1111/j.1365-2249.2009.03889.x
CXCR7 is inducible by HTLV-1 Tax and promotes growth and survival of HTLV-1-infected T cells, International Journal of Cancer, vol.71, issue.Part 8, pp.2229-2235, 2009. ,
DOI : 10.1002/ijc.24612
G??13 and Rho Mediate Endosomal Trafficking of CXCR4 into Rab11+ Vesicles upon Stromal Cell-Derived Factor-1 Stimulation, The Journal of Immunology, vol.186, issue.2, pp.951-958, 2011. ,
DOI : 10.4049/jimmunol.1002019
WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12, Blood, vol.105, issue.6, pp.2449-2457, 2005. ,
DOI : 10.1182/blood-2004-06-2289
URL : https://hal.archives-ouvertes.fr/pasteur-00166808
CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity, The Journal of Experimental Medicine, vol.71, issue.2, pp.327-339, 2011. ,
DOI : 10.4049/jimmunol.0900269
A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells, Journal of Leukocyte Biology, vol.84, issue.4, pp.1130-1140, 2008. ,
DOI : 10.1189/jlb.0208088
Chapter 2 CXCR4 and Mobilization of Hematopoietic Precursors, Methods Enzymol, vol.460, pp.57-90, 2009. ,
DOI : 10.1016/S0076-6879(09)05203-3
B Lymphocyte Chemotaxis Regulated in Association with Microanatomic Localization, Differentiation State, and B Cell Receptor Engagement, The Journal of Experimental Medicine, vol.154, issue.5, pp.753-762, 1998. ,
DOI : 10.1002/eji.1830270729
CXCR4/CXCL12 Hyperexpression Plays a Pivotal Role in the Pathogenesis of Lupus, The Journal of Immunology, vol.182, issue.7, pp.4448-4458, 2009. ,
DOI : 10.4049/jimmunol.0801920
A model for harmonizing flow cytometry in clinical trials, Nature Immunology, vol.73, issue.11, pp.975-978, 2010. ,
DOI : 10.1016/j.immuni.2009.09.007
Functional Consequences of Human Lymphocyte Cryopreservation, Journal of Immunotherapy, vol.34, issue.8, pp.588-596, 2011. ,
DOI : 10.1097/CJI.0b013e31822bc3d0
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006, Arthritis & Rheumatism, vol.60, issue.Suppl 1, pp.1681-1688, 1995. ,
DOI : 10.1002/art.30293
Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico, Rheumatology, vol.48, issue.11, pp.1392-1397, 2009. ,
DOI : 10.1093/rheumatology/kep266
Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo, J Leukoc Biol, vol.65, pp.691-699, 1999. ,
The role of Tumor Necrosis Factor-alpha (TNF-??) in the pathogenesis of systemic lupus erythematosus, Cytokine, vol.56, issue.3, pp.537-543, 2011. ,
DOI : 10.1016/j.cyto.2011.08.026
Interleukin 17 acts in synergy with B cell???activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus, Nature Immunology, vol.10, issue.7, pp.778-785, 2009. ,
DOI : 10.1038/ni.1741
URL : https://hal.archives-ouvertes.fr/hal-00539348
Interleukin 17???producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice, Nature Immunology, vol.1, issue.2, pp.166-175, 2008. ,
DOI : 10.1038/ni1552
Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus, Eur Cytokine Netw, vol.18, pp.181-187, 2007. ,
Cxcr7 Controls Neuronal Migration by Regulating Chemokine Responsiveness, Neuron, vol.69, issue.1, pp.77-90, 2011. ,
DOI : 10.1016/j.neuron.2010.12.006
B cell homeostasis and plasma cell homing controlled by Kruppel-like factor 2, Proceedings of the National Academy of Sciences, vol.108, issue.2, pp.710-715, 2011. ,
DOI : 10.1073/pnas.1012858108
Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7, Proceedings of the National Academy of Sciences, vol.104, issue.37, pp.14759-14764, 2007. ,
DOI : 10.1073/pnas.0702229104
CXC Chemokine Receptor 7 (CXCR7) Regulates CXCR4 Protein Expression and Capillary Tuft Development in Mouse Kidney, PLoS ONE, vol.7, issue.8, p.42814, 2012. ,
DOI : 10.1371/journal.pone.0042814.s002
CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells, Journal of Cell Science, vol.123, issue.7, pp.1081-1088, 2010. ,
DOI : 10.1242/jcs.062810